General Medicine and Primary Care

Host: Peter Buch, MD, FACG, AGAF, FACP

Guest: Douglas K. Rex, MD

Millions of colonoscopies are performed each year in the United States, but which indicators should we be using to measure the quality of these procedures? Dr. Peter Buch is joined by Dr. Douglas Rex, Distinguished Professor Emeritus of Medicine at Indiana University School of Medicine, to discuss the importance of these indicators.

Host: Carol Wysham

Guest: Irl Hirsch, MD, MACP

How is technology like continuous glucose monitors impacting the way we care for patients with diabetes, especially amid the COVID-19 pandemic? To learn more about the technological advancements in diabetes care, Dr. Carol Wysham speaks with Dr. Irl Hirsch, a Professor in Diabetes Treatment and Teaching Chair at the University of Washington School of Medicine in Seattle, Washington.

Host: Carol Wysham

Guest: Irl Hirsch, MD, MACP

Why was there so much discordance between some patients’ GMI and their measured A1C? That’s the exact question Dr. Irl Hirsch from the University of Washington School of Medicine asked and explored in a paper he recently co-authored. And now Dr. Hirsch is here to share his findings.

Host: Jennifer Caudle, DO

Guest: Dalilah Restrepo, MD

A locum tenens opportunity brought a physician to New Zealand, but the onset of the COVID-19 pandemic gave her the opportunity to stay. Dr. Dalilah Restrepo, a former infectious disease specialist at the AHF Healthcare Center, discusses her locum tenens experience and discusses how New Zealand has responded to the pandemic.

Host: John Buse, MD, PhD

Guest: Anne Louise Peters, MD

SGLT-2 inhibitors have been authorized for diabetic patients in Europe, but is it close to receiving FDA approval in the U.S.? Dr. Anne Peters of USC speaks with Dr. John Buse about SGLT-2 inhibitors and considerations for diabetic ketoacidosis, heart failure, and chronic kidney disease.

Host: David Weisman, MD

Guest: Adil Javed, MD, PhD

How can providers help mitigate the symptoms of a disease as debilitating as multiple sclerosis? Dr. David Weisman examines management strategies for patients with multiple sclerosis with is Dr. Adil Javed, a board-certified neurologist and an Associate Professor of Neurology at the University of Chicago.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Ping Zhang, PhD, FAMIA

The pandemic continues to wreak havoc across the world, but a new deep learning computer model may have discovered ten potential treatment options to combat COVID-19. Dr. Charles Turck sits down with Dr. Ping Zhang, who leads the Artificial Intelligence in Medicine Lab and a faculty member at the Translational Data Analytics Institute at The Ohio State University, to discuss his team's findings.

Published March 29, 2021

Host: Neilanjan Nandi, MD

Guest: Folasade P. May, MD, PhD, MPhil

Racial and ethnic bias prevent patients with colorectal cancer from receiving the highest quality of care. Dr. Neil Nandi is joined by Dr. Fola May, Assistant Professor of Medicine at UCLA, to discuss racial inequalities in access to care and screening for patients with colorectal cancer.

Host: John Buse, MD, PhD

How early should we start screening for diabetes, and what tools are available to us? In recognition of Diabetes Alert Day, Dr. John Buse reviews the current screening tests and recommendations for those who are at risk of diabetes.

Host: John Buse, MD, PhD

It can be tempting for patients to undermine the seriousness of diabetes. But in recognition of Diabetes Alert Day, Dr. John Buse explains why we need to set the record straight.